
MDExam Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: mainstream telehealth GLP-1 access
MDExam scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Included
No insurance needed · Vetted by our editors
Telehealth provider whose GLP-1 program bundles telemedicine visits, nutrition and exercise coaching and the medication into one price — stated as as low as $225 per month for semaglutide and $258 for tirzepatide. Note the site publishes a second, lower figure for semaglutide on a different page without saying what period it covers.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to MDExam
Editorial score · methodology
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
MDExam at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $225/mo
- What's included
- Medication · Consult · Coaching
- FDA status
- No FDA warning letter on record
How we scored MDExam
Each dimension is scored algorithmically from MDExam’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.2/10At $225/mo, MDExam runs about 33% above the $169 median for GLP-1 providers.
Effectiveness25%
8.1/10MDExam offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience — consult included in the price; 2 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-15).
Accessibility10%
6.1/10MDExam's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
7.2/10Coaching/dietitian access included.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this MDExam review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with MDExam
We walked MDExam’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Fill out the medical questionnaire to see if you qualify and get a customized plan.
- 2Select your medication; the team recommends the best program based on your medical history and weight-loss goal.
- 3Doctors review your chart and message you with any follow-up questions.
- 4Medication should arrive within about a business week.
- Text-based consultations with a medical provider; check-ins and progress tracking managed in an online portal.
- Compounded GLP-1 medications (semaglutide/tirzepatide); no insurance required.
- No specific price is shown before the questionnaire ('See If You Qualify').
- An injection-free option is advertised.
- Cites 86,000+ patients and a 93% success rate; medication ships from a mail-order pharmacy.
GLP-1 medications MDExam offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
⛔ MDEXAM PUBLISHES TWO DIFFERENT PRICES FOR THIS SAME PRODUCT. /injectable-semaglutide renders 'Semaglutide Weight Loss Program | Price | $192' with NO billing period stated anywhere, while /medications/injectable-semaglutide renders 'Price | $225' for the identical product. We record $225 because it is the ONLY figure the site ever attaches to a period: 'Our program is priced as low as $225 per month, which includes telemedicine visits, nutrition and exercise coaching, and medication.' Treat $192 as an unlabelled promotional figure until a checkout can be walked — /checkout renders an empty body without a session.
'Injectable Tirzepatide Program | Price | $258'. ⚠ NO BILLING PERIOD IS STATED ON THIS CARD EITHER. It is recorded as monthly on the strength of the site-wide FAQ, which frames the whole program as 'as low as $225 per month ... includes telemedicine visits, nutrition and exercise coaching, and medication' — $258 sits above that floor, consistent with a monthly tirzepatide rate. That is an inference from the program framing, not a quoted period, and it should be re-checked at checkout.
Ready to get started?
Plans and promotions change often — check MDExam's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide available
Watch-outs
- Pricing not publicly disclosed
MDExam: a Miami telehealth clinic betting on one all-inclusive price
MDExam is a Florida-based telehealth practice, run out of Miami, that prescribes compounded semaglutide and tirzepatide through licensed providers. Its pitch is refreshingly simple in a market full of add-on fees: one bundled monthly charge that wraps the doctor visit, the medication, and ongoing nutrition and exercise coaching into a single line item. If you hate surprise charges and want the GLP-1, the clinician, and the hand-holding under one roof, MDExam is built for exactly that mainstream patient. It is not the pick for anyone who wants brand-name Ozempic or Zepbound, or who needs to confirm coverage in their specific state before signing up.
How the pricing actually works
MDExam sells a flat, all-inclusive membership rather than charging separately for the consult, the drug, and the coaching. On its own site the clinic advertises a rate that starts in the low-to-mid two hundreds a month, and that figure is meant to cover the telemedicine visit, the medication itself, and the nutrition-and-exercise coaching together. That bundling is the whole point: many competitors quote a low medication price and then layer on a separate consult fee or a monthly membership, so the sticker you see isn't the sticker you pay. MDExam's number is designed to be the number.
One honest caveat, and it matters: our structured pricing record for MDExam is currently empty because the clinic has historically kept rates off its public pages, and the advertised all-inclusive figure showed up more recently. For context, the category median across the providers we track sits around $169 a month. Treat MDExam's quote as a starting point and confirm your exact monthly cost — and whether it changes after the first month or at higher doses — in writing before you pay.
The medications and how they're dispensed
MDExam offers the two GLP-1 molecules that matter most for weight loss: semaglutide (the compound in Ozempic and Wegovy) and tirzepatide (the compound in Mounjaro and Zepbound). Having both on the menu is genuinely useful, because it means a provider can start you on semaglutide and move you to the typically more potent tirzepatide if your results stall, without making you switch clinics.
- Semaglutide — the more established, widely studied GLP-1 option, often the starting point.
- Tirzepatide — the dual-action molecule many patients move to for stronger appetite control and weight loss.
- Bundled support — the membership includes nutrition and exercise coaching, not just the prescription.
These are compounded formulations dispensed after a licensed-provider visit, not brand-name pens. That keeps the price down, but it also means you are getting a pharmacy-compounded version rather than the FDA-approved branded product — an important distinction if your goal specifically requires Wegovy or Zepbound.
What actually sets MDExam apart
Two things make MDExam distinct. The first is scale for a clinic of its type: it reports more than 86,000 total patients treated, which is a meaningful track record and suggests a real operational engine behind the website rather than a thin storefront. The second is the all-in-one bundle. Plenty of telehealth brands sell the medication cheaply and then nickel-and-dime you on visits and coaching; MDExam folds the coaching into the base membership, so the behavioral side of weight loss — the part that actually keeps the weight off — isn't an upsell.
Who should choose it, and who should skip it
Choose MDExam if you want a no-math, everything-included monthly price, you're comfortable with compounded semaglutide or tirzepatide, and you value built-in coaching alongside the prescription. The single-bundle structure is especially friendly to first-timers who don't want to decode a fee table.
Skip it if you need brand-name medication, if you want every cost and refund term spelled out on a public page before you talk to anyone, or if confirming availability in your exact state is a dealbreaker. MDExam does not publicly disclose its full list of states served, so you'll have to verify your location is covered during sign-up rather than checking a map in advance.
Trust, safety, and medical oversight
On the safety ledger, MDExam carries no FDA warning letters in our records, and prescriptions are written by licensed providers operating out of an identifiable Florida practice — both reassuring signs. The weaker spots are transparency-related rather than safety scandals: the clinic doesn't publish a named compounding-pharmacy partner with accreditation details in our file, and its pricing and state coverage have lived mostly behind the sign-up flow. None of that is disqualifying, but it does mean you're trusting the intake process to surface the specifics. You can see how we weigh disclosure, oversight, and pricing transparency in our scoring methodology.
Bottom line
MDExam is a solid, mainstream choice for someone who wants compounded semaglutide or tirzepatide with the visit and coaching folded into one predictable monthly payment, backed by a clinic with a large patient base. Its all-inclusive pricing is its best feature and its public-transparency gaps are its real weakness. Go in ready to confirm the exact monthly cost, the medication's compounded status, and your state's availability in writing — do that, and the simplicity it's selling is worth a look.
Shopping around? MadeMed ($219/month) and Sunlight ($88/month) are the nearest alternatives to MDExam in our rankings.
The Bottom Line
MDExam scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with MDExam?
Starting at $225/month. See current pricing and start your free consultation.
MDExam might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this MDExam review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MDExam's current pricing
Plans start at $225/month. Start your free consultation to check eligibility and today's price.